Cargando…
Tau post-translational modifications in wildtype and human amyloid precursor protein transgenic mice
The microtubule-associated protein tau has been implicated in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative disorders. Reducing tau levels ameliorates AD-related synaptic, network, and behavioral abnormalities in human amyloid precursor protein (hAPP) transgenic mice....
Autores principales: | Morris, Meaghan, Knudsen, Giselle M., Maeda, Sumihiro, Trinidad, Jonathan C., Ioanoviciu, Alexandra, Burlingame, Alma L., Mucke, Lennart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049446/ https://www.ncbi.nlm.nih.gov/pubmed/26192747 http://dx.doi.org/10.1038/nn.4067 |
Ejemplares similares
-
Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice
por: Maeda, Sumihiro, et al.
Publicado: (2016) -
Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
por: Morris, Meaghan, et al.
Publicado: (2011) -
Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits
por: Harris, Julie A., et al.
Publicado: (2012) -
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
por: Li, Tommy, et al.
Publicado: (2018) -
A Minimal Anaphase Promoting Complex/Cyclosome (APC/C) in Trypanosoma brucei
por: Bessat, Mohamed, et al.
Publicado: (2013)